ANI Pharmaceuticals Inc (ANIP): Operating Cash Flow
$185.22M
Year ended 2025-12-31
$189.47M
Trailing 12 months to 2026-06-30
+64.7%
5-year compound annual growth
+26.8%
10-year compound annual growth
| Period ended | Operating Cash Flow | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $185.22M | +189.3% | 2026-02-27, From 2025-01-01 |
| 2024-12-31 | $64.02M | -46.2% | 2026-02-27, From 2024-01-01 |
| 2023-12-31 | $118.96M | n/m | 2026-02-27, From 2023-01-01 |
| 2022-12-31 | -$31.20M | n/m | 2025-02-28, From 2022-01-01 |
| 2021-12-31 | $3.32M | -78.2% | 2024-02-29, From 2021-01-01 |
| 2020-12-31 | $15.27M | -66.5% | 2023-03-09, From 2020-01-01 |
| 2019-12-31 | $45.63M | -32.0% | 2022-03-15, From 2019-01-01 |
| 2018-12-31 | $67.07M | +70.2% | 2021-03-11, From 2018-01-01 |
| 2017-12-31 | $39.42M | +43.5% | 2020-02-27, From 2017-01-01 |
| 2016-12-31 | $27.47M | +59.1% | 2019-02-27, From 2016-01-01 |
| 2015-12-31 | $17.26M | -21.6% | 2018-02-27, From 2015-01-01 |
| 2014-12-31 | $22.03M | n/m | 2017-03-02, From 2014-01-01 |
| 2013-12-31 | -$5.48M | n/m | 2016-02-23, From 2013-01-01 |
| 2012-12-31 | -$137.0K | n/a | 2014-02-28, From 2012-01-01 |
Operating Cash Flow at similar companies
| Company | Year ended | Operating Cash Flow | Change YoY |
|---|---|---|---|
| ANI Pharmaceuticals Inc (ANIP) | 2025-12-31 | $185.22M | +189.3% |
| Harmony Biosciences Holdings, Inc. (HRMY) | 2025-12-31 | $348.20M | +58.4% |
| Arrowhead Pharmaceuticals, Inc. (ARWR) | 2025-09-30 | $179.55M | n/m |
| Ionis Pharmaceuticals Inc (IONS) | 2025-12-31 | -$268.58M | n/m |
| Madrigal Pharmaceuticals, Inc. (MDGL) | 2025-12-31 | -$189.55M | n/m |
| Collegium Pharmaceutical, Inc (COLL) | 2025-12-31 | $329.32M | +60.7% |
| Corcept Therapeutics Inc (CORT) | 2025-12-31 | $142.00M | -28.4% |
| Emergent BioSolutions Inc. (EBS) | 2025-12-31 | $170.60M | +190.6% |
| Acadia Pharmaceuticals Inc (ACAD) | 2025-12-31 | $109.84M | -30.4% |
Compare ANIP, HRMY, ARWR, IONS side by side · Screen every company in Pharmaceutical Preparations ↗